ArticleMedicine2018
Primary functioning hepatic paraganglioma mimicking hepatocellular carcinoma: A case report and literature review.
Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 18 citations in OpenAlex.
- Primary Hepatic Paraganglioma Mimicking Hepatocellular Carcinoma: A Diagnostic Challenge and Literature Review.Cureus · 2026Article
- Case Report: A rare case of primary hepatic paraganglioma: a mimicker of hepatocellular carcinoma.Frontiers in oncology · 2025Article
- Primary hepatic paraganglioma with megacolon: A case report.Oncology letters · 2023Article
- Paraganglioma arising from the liver and abutting the heart.BMJ case reports · 2023Article
- The Complex Histopathological and Immunohistochemical Spectrum of Neuroendocrine Tumors-An Overview of the Latest Classifications.International journal of molecular sciences · 2023Review
- Primary Functioning Hepatic Paraganglioma Treated by Laparoscopy: A Case Report.Journal of clinical medicine · 2022Article
- Primary hepatic paraganglioma mimicking hepatocellular carcinoma: a case report.Translational cancer research · 2022Article
- Tumour to tumour metastasis: case of a carotid body paraganglioma metastatic to a hepatocellular adenoma.BMJ case reports · 2022Article
- Paraganglioma masquerading as a primary liver lesion: A rare entity discovered during surgery.Clinical case reports · 2022Article
- Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.Frontiers in endocrinology · 2022Review
- Primary Multifocal Hepatic PEComa: A Rarely Encountered Diagnostic Dilemma.Journal of gastrointestinal cancer · 2020Article
- Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine.Cancers · 2019Review
- Hepatic paraganglioma hiding as a slowly growing lesion for 24 years: a diagnostic conundrum.BMJ case reports · 2019Article
- The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations.Journal of clinical medicine · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHepatic paraganglioma (HPGL) originates from the sympathetic nervous tissue in the liver, and is an extremely rare type of the sympathetic paragangliomas. Till now, only 11 HPGL cases have been reported. CASE PRESENTATION: A 49-year-old woman presented to our hospital with a lesion in the right lobe of the liver, which grew from 2 to 6 cm in 2 years. In addition, she had a 6-year history of diabetes. The patient was initially diagnosed as hepatocellular carcinoma and hepatectomy was performed. Surgical resection of the liver lesion was successful, but the blood pressure rose and fell sharply when the lesion was being removed. The pathological examination of the liver lesion showed that it was HPGL. After the operation, the patient recovered uneventfully. Follow-up examination showed the blood glucose level went back to the normal range in 20 days after the operation, and MRI and I-MIBG scan showed that there was no evidence of recurrence and metastasis in >2 years.
conclusionBy means of reporting this case and reviewing 11 reported cases, we conclude that the incidence of HPGLs is extremely low and the clinical and radiological characteristics of HPGLs are nonspecific; thus, it is hard to diagnose HPGLs correctly. Surgical resection is curative therapy for HPGLs, whereas the removing of HPGLs may cause the releasing of catecholamine, and then lead to hypertension crisis and arrhythmia. Thus, antihypertensive therapy is necessary during the operation. Follow-ups after the operation are important for HPGL patients, for pathological examinations are not sufficient to differ malignant HPGLs from benign ones, and follow-ups are helpful for HPGL patients to find the recurrent foci or metastases timely.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.